
Yan Leyfman
Jun 6, 2025, 16:15
Yan Leyfman: IFN-γR Knockout Improves CD28 CAR T Cell Function in Tumor Models
Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared a post on LinkedIn:
“New findings from Dr. Marcela Maus and team at Mass General Hospital reveal a surprising twist in CAR T-cell therapy:
While IFN-γ is often seen as a key player in immunotherapy, this study shows it may actually induce apoptosis in CD28-based CAR T cells, limiting their persistence and efficacy.
Knockout of IFN-γ receptor (IFN-γR) enhanced CAR T cell survival, memory, and anti-tumor activity – especially in solid tumors where CAR T success has been more elusive.
IFN-γR KO led to:
Better tumor control
Longer survival
Durable immune memory
Enhanced tumor cell apoptosis
This could mark a major advance in optimizing CAR T design for both liquid and solid cancers.”
Title: IFN-γ–resistant CD28 CAR T cells demonstrate increased survival, efficacy, and durability in multiple murine tumor models
Journal: Science Translational Medicine
Authors: Stefanie R. Bailey, Hana N. Takei, Giulia Escobar, Michael C. Kann, Amanda A. Bouffard, Tamina Kienka, Valentina M. Supper, Alexander Armstrong, Diego Salas-Benito, Merle K. Phillips, Filippo Birocchi, Sonika Vatsa, Harrison Silva, Irene Scarfò, Marc Wehrli, Korneel Grauwet, Eli P. Darnell, Charlotte E. Graham, Mark B. Leick, Felix Korell, Trisha R. Berger, Marcela V. Maus
More posts featuring Yan Leyfman on OncoDaily.
Alexander Armstrong
Amanda A. Bouffard
cancer
CAR T-CELL
CAR T-cell therapy
Charlotte E. Graham
Diego Salas-Benito
Eli P. Darnell
Felix Korell
Filippo Birocchi
Giulia Escobar
Hana N. Takei
Harrison Silva
IFN-γ
immunotherapy
Irene Scarfò
Korneel Grauwet
liquid cancers
Marc Wehrli
Marcela Maus
Marcela V. Maus
Mark B. Leick
Mass General Hospital
MedNews Week
Merle K. Phillips
Michael C. Kann
OncoDaily
Oncology
Science Translational Medicine
solid cancers
Sonika Vatsa
Stefanie R. Bailey
Tamina Kienka
Trisha R. Berger
Valentina M. Supper
Yan Leyfman
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 6, 2025, 15:07